ZA896916B - Etoposide solutions - Google Patents

Etoposide solutions

Info

Publication number
ZA896916B
ZA896916B ZA896916A ZA896916A ZA896916B ZA 896916 B ZA896916 B ZA 896916B ZA 896916 A ZA896916 A ZA 896916A ZA 896916 A ZA896916 A ZA 896916A ZA 896916 B ZA896916 B ZA 896916B
Authority
ZA
South Africa
Prior art keywords
etoposide
solutions
solution
dimethylisosorbide
formulated
Prior art date
Application number
ZA896916A
Other languages
English (en)
Inventor
Gururaj Bykadi
Bykadi Gururaj
Murray A Kaplan
A Kaplan Murray
Richard G Corrao
G Corrao Richard
Edward J Bara
J Bara Edward
Ismat Ullah
Ullah Ismat
Shreeram Marahari Agharkar
Marahari Agharkar Shreeram
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA896916B publication Critical patent/ZA896916B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA896916A 1988-09-12 1989-09-11 Etoposide solutions ZA896916B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/243,392 US4927638A (en) 1986-10-08 1988-09-12 Etoposide solutions

Publications (1)

Publication Number Publication Date
ZA896916B true ZA896916B (en) 1991-08-28

Family

ID=22918600

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896916A ZA896916B (en) 1988-09-12 1989-09-11 Etoposide solutions

Country Status (14)

Country Link
US (1) US4927638A (fr)
EP (1) EP0359184B1 (fr)
JP (1) JPH02115126A (fr)
KR (1) KR900004322A (fr)
AT (1) ATE83150T1 (fr)
AU (1) AU616049B2 (fr)
DE (1) DE68903814T2 (fr)
DK (1) DK446889A (fr)
FI (1) FI894225A (fr)
GR (1) GR3006501T3 (fr)
IE (1) IE892898L (fr)
IL (1) IL91598A0 (fr)
PT (1) PT91682B (fr)
ZA (1) ZA896916B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910014122A (ko) * 1990-01-19 1991-08-31 디께다 가즈히꼬 에토포시드-2-디메틸아미노 화합물의 동결건조 제제
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
SI1033128T2 (sl) 1993-09-28 2012-02-29 Scherer Gmbh R P Izdelava mehke Ĺľelatinaste kapsule
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
CA2188297C (fr) * 1994-04-28 2006-12-19 Frederick Herman Hausheer Formulation stable sous forme lactone de camptothecine ou 7-ethyle camptothecine
AU6390096A (en) * 1995-07-20 1997-02-18 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
AU4609200A (en) * 1999-01-28 2000-08-18 Shashikant Prabhudas Kurani Novel injectable antimalarial compositions of artemisinin
WO2001095939A1 (fr) * 2000-06-12 2001-12-20 Smithkline Beecham Corporation Nouvelles compositions de dispersions solides
WO2006034147A2 (fr) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions et procedes de preparation et d'administration de medicaments faiblement solubes dans l'eau
US20090252702A1 (en) * 2006-04-24 2009-10-08 Bruce Medical Ab Polymer-based anti-cancer agents
US9011843B2 (en) * 2006-12-14 2015-04-21 Master Supplements, Inc. Formulations including monovalent alginate to enhance effectiveness of administered digestive enzymes
US20110135702A1 (en) * 2009-12-09 2011-06-09 Hoffman Douglas R Sporicidal composition for clostridium difficile spores
US9578879B1 (en) 2014-02-07 2017-02-28 Gojo Industries, Inc. Compositions and methods having improved efficacy against spores and other organisms
AU2015214041B2 (en) 2014-02-07 2018-12-06 Gojo Industries, Inc. Compositions and methods with efficacy against spores and other organisms

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3219529A (en) * 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US3699230A (en) * 1971-03-12 1972-10-17 Robins Co Inc A H Dimethylisosorbide solvent for muscle relaxant drugs
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
EP0120907A1 (fr) * 1982-10-13 1984-10-10 Aston Molecules Limited Preparations pharmaceutiques utilisees en therapie antitumorale
NZ211078A (en) * 1984-03-19 1987-08-31 Bristol Myers Co Oral dosage form of etoposide
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
JPS60239414A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド溶液の変色抑制方法
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS60239415A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド注射剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤

Also Published As

Publication number Publication date
EP0359184A1 (fr) 1990-03-21
AU4130189A (en) 1990-03-15
JPH02115126A (ja) 1990-04-27
IE892898L (en) 1990-03-12
AU616049B2 (en) 1991-10-17
GR3006501T3 (fr) 1993-06-30
PT91682B (pt) 1995-05-31
IL91598A0 (en) 1990-04-29
KR900004322A (ko) 1990-04-12
US4927638A (en) 1990-05-22
EP0359184B1 (fr) 1992-12-09
DE68903814D1 (de) 1993-01-21
DK446889D0 (da) 1989-09-11
FI894225A (fi) 1990-03-13
ATE83150T1 (de) 1992-12-15
DE68903814T2 (de) 1993-04-08
DK446889A (da) 1990-03-13
PT91682A (pt) 1990-03-30
FI894225A0 (fi) 1989-09-07

Similar Documents

Publication Publication Date Title
ZA896916B (en) Etoposide solutions
IT8449041A1 (it) Articoli stampati a pressofusione in particolare capsule
EP0359007A3 (en) Structure for temperature detection in a package
HUT58202A (en) Process for producing and utilizing porfirine derivatives
EP0192989A3 (en) Integrated circuit with a semiconductor capacitor and process for its production
FR2646954B1 (fr) Reacteurs nucleaires refroidis a l'eau
ZA868600B (en) An optically pure compound and a process for its preparation
EP0287383A3 (en) Superconducting ceramic film and a method of manufacturing the same
EP0218114A3 (en) A film and a process for its production
GB2232799B (en) A word processor with attribute functions
EP0194499A3 (en) Process for diffusing impurities into a semiconductor body
HUT49563A (en) Process for producing optically active hydroxy-benzyl-amin derivatives, optically active amine-boron compounds containing them, and process for producing other optically active compounds with utilizing former optically active amine-boron compounds
EP0408753A4 (en) Process for forming superconducting thin film
EP0357321A3 (en) Superconducting transistor
GB8805412D0 (en) Baby bottle liner
GB8611154D0 (en) (1 4)benzodioxin &(1 4)benzoxazine derivatives
ZA893441B (en) Pharmaceutical solutions of triamterene
PH24957A (en) Azolidinedione derivatives
SG48776A1 (en) Optically active compounds and a process for producing these compounds
GB8803281D0 (en) Development accelerators
IE882666L (en) Azolidinedione derivatives
GB8820186D0 (en) Hydroxyheteroaryl derivatives
PL253487A2 (en) Hygenic baby's soother
DK620987D0 (da) Renin-inhibitorer med et lactam-pseudodipeptid
HU905506D0 (en) Process for producing optically active hydroxy-benzyl-amine derivatives and optically active amine-boron compounds containing the former ones